查看購物車
  • Simplified Chinese
  • English
  • Japanese
胚胎著床前基因檢測市場規模、佔有率和成長分析（按檢測類型、技術、類別、最終用戶和地區分類）—產業預測，2025-2032年
市場調查報告書
商品編碼
1865216

胚胎著床前基因檢測市場規模、佔有率和成長分析（按檢測類型、技術、類別、最終用戶和地區分類）—產業預測，2025-2032年

Preimplantation Genetic Testing Market Size, Share, and Growth Analysis, By Test Type, By Technology, By Category, By End-User, By Region - Industry Forecast 2025-2032
出版日期: | 出版商: SkyQuest | 英文 185 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球胚胎著床前基因檢測市場規模預計在 2023 年達到 8.775 億美元，從 2024 年的 9.4331 億美元成長到 2032 年的 16.8238 億美元，在預測期（2025-2032 年）內複合年成長率為 7.5%。

市場分析顯示，胚胎胚胎著床前基因檢測需求的成長主要受以下因素驅動：遺傳疾病的增加、不孕症發生率的上升、基因篩檢技術的進步以及體外受精（IVF）基礎設施的擴展。遺傳異常的高發生率推動了早期基因檢測的普及，而與生活方式和環境因素相關的不孕症發病率上升則推動了對IVF解決方案的需求。胚胎著床前基因檢測已成為生殖醫學的重要組成部分，因為它能提高IVF的成功率並減少所需的治療週期數。此外，公眾對遺傳疾病和孕產婦健康的日益關注也推動了市場成長。然而，高昂的治療費用、倫理問題、人力資源短缺以及臨床結果的不確定性等挑戰可能會阻礙未來的市場滲透。

全球胚胎著床前基因檢測市場促進因素

全球胚胎著床前遺傳學檢測市場正經歷顯著成長，這主要得益於全球試管嬰兒中心、生育診所和專業診斷實驗室的激增，從而推高了對這類檢測服務的需求。此外，尤其是在發展中地區，對改善生殖健康基礎設施的大量投資也為胚胎著床前遺傳學檢測服務提供者開闢了新的機會。生育服務基礎設施的擴建是推動市場發展的關鍵因素，因為它提高了基因檢測的可及性和認知度，最終為全球胚胎胚胎著床前遺傳學檢測產業帶來了光明的前景。

限制全球胚胎著床前基因檢測市場的因素

全球胚胎著床前遺傳學檢測市場面臨嚴峻挑戰，因為這些檢測項目費用高昂，並顯著增加了體外受精（IVF）的總成本。這種經濟負擔可能會使許多夫婦，尤其是經濟條件較差的夫婦，放棄選擇這項治療方案。高昂的費用主要源自於對先進技術、一流實驗室基礎設施和專業人才的需求。此外，缺乏保險覆蓋也加劇了這個問題，進一步限制了中低收入者獲得這項服務的機會，並阻礙了胚胎著床前遺傳學檢測的廣泛應用。

全球胚胎著床前基因檢測市場趨勢

全球胚胎著床前遺傳學檢測市場正加速向非侵入性遺傳學檢測方法轉型，這主要得益於消費者對更安全、更微創的檢測方式日益成長的需求。利用分析胚胎培養液中游離DNA的技術創新，無需進行傳統的胚胎細胞萃取，從而最大限度地減少了對胚胎的潛在損傷。這項進步不僅提高了檢測過程的安全性和可行性，也符合消費者對微創醫療程序的日益成長的偏好。因此，隨著這些先進調查方法的應用，預計市場將顯著成長。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場概覽
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數（2024）
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 技術評估
  • 監管環境

全球胚胎著床前基因檢測市場規模（依檢測類型分類）、複合年成長率（2025-2032 年）

  • 市場概覽
  • 胚胎著床前遺傳學診斷（PGD）
  • 胚胎著床前遺傳學篩檢（PGS）/非整倍篩檢
  • HLA型檢測/胚胎配對
  • 其他

全球胚胎著床前基因檢測市場規模（依技術分類）、複合年成長率（2025-2032 年）

  • 市場概覽
  • 次世代定序（NGS）
  • 聚合酵素鏈鎖反應（PCR）
  • 螢光原位雜合反應（FISH）
  • 比較基因組雜合反應/微陣列
  • 單核苷酸多態性（SNP）和基於人工智慧的平台

全球胚胎著床前基因檢測市場規模（按類別分類）、複合年成長率（2025-2032 年）

  • 市場概覽
  • 試劑和耗材
  • 設備/平台
  • 軟體和生物資訊學服務

全球胚胎著床前基因檢測市場規模（以最終用戶分類），複合年成長率（2025-2032 年）

  • 市場概覽
  • 不孕症診所/試管嬰兒中心
  • 醫院和輔助生殖技術（ART）中心
  • 診斷實驗室

全球胚胎著床前基因檢測市場規模（按地區分類）、複合年成長率（2025-2032 年）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位（2024 年）
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析（2024 年）
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2022-2024年營收年比比較

主要企業簡介

  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • CooperSurgical Inc.
  • Abbott Laboratories
  • Natera Inc.
  • Genea Limited
  • Roche Holding AG
  • Agilent Technologies Inc.
  • Labcorp Holdings Inc.
  • Invitae Corp.
  • Oxford Gene Technology IP
  • Yikon Genomics
  • Bioarray SL
  • Genesis Genetics
  • Fulgent Genetics
  • Igenomix
  • Vitrolife AB
  • MedGenome Labs
  • CombiMatrix Corporation

結論與建議

簡介目錄
Product Code: SQMIG35D2364

Global Preimplantation Genetic Testing Market size was valued at USD 877.5 million in 2023 and is poised to grow from USD 943.31 million in 2024 to USD 1682.38 million by 2032, growing at a CAGR of 7.5% during the forecast period (2025-2032).

Market insights indicate that the demand for preimplantation genetic testing is significantly driven by the increasing prevalence of genetic disorders, the rising rates of infertility, and advancements in genetic screening technologies, alongside the expansion of IVF infrastructure. The high incidence of genetic abnormalities fosters the adoption of early genetic testing, while rising infertility is linked to lifestyle factors and environmental influences, amplifying the need for IVF solutions. Preimplantation genetic testing enhances IVF success rates and reduces the number of cycles needed, becoming essential in reproductive health. Additionally, growing public awareness about genetic diseases and maternal health promotes market growth. However, challenges such as high procedure costs, ethical concerns, workforce shortages, and uncertainties in clinical outcomes could hinder market penetration going forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Preimplantation Genetic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Preimplantation Genetic Testing Market Segments Analysis

Global Preimplantation Genetic Testing Market is segmented by Test Type, Technology, Category, End-User and region. Based on Test Type, the market is segmented into Preimplantation Genetic Diagnosis (PGD), Preimplantation Genetic Screening (PGS) / Aneuploidy Screening, HLA Typing / Embryo Matching and Others. Based on Technology, the market is segmented into Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Comparative Genomic Hybridization / Microarray and Single-Nucleotide Polymorphism (SNP) & AI-based Platforms. Based on Category, the market is segmented into Reagents & Consumables, Instruments / Platforms and Software & Bioinformatics Services. Based on End-User, the market is segmented into Fertility Clinics / IVF Centres, Hospitals & Assisted Reproductive Technology (ART) Centres and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Preimplantation Genetic Testing Market

The global preimplantation genetic testing market is experiencing significant growth due to the surge in the number of IVF centers, fertility clinics, and specialized diagnostic laboratories worldwide, which enhances the demand for these testing services. Additionally, substantial investments aimed at improving reproductive healthcare infrastructure, particularly in developing regions, are opening new avenues for preimplantation genetic testing providers. This expansion in fertility service infrastructure is a key factor propelling the market forward, as it increases accessibility and awareness of genetic testing options, ultimately leading to a brighter outlook for the preimplantation genetic testing industry on a global scale.

Restraints in the Global Preimplantation Genetic Testing Market

The global preimplantation genetic testing market faces significant challenges due to the high costs associated with these procedures, which considerably increase the overall expenses of in vitro fertilization (IVF). This financial burden can discourage many couples, particularly those with limited financial means, from pursuing such options. The elevated costs are primarily a result of the need for advanced technology, state-of-the-art laboratory infrastructure, and specialized expertise. Additionally, the absence of reimbursement options exacerbates the issue, further limiting access for individuals in low- and middle-income regions, thus hindering wider adoption of preimplantation genetic testing.

Market Trends of the Global Preimplantation Genetic Testing Market

The Global Preimplantation Genetic Testing market is increasingly witnessing a shift towards non-invasive genetic testing approaches, driven by the rising demand for safer, minimally invasive procedures. Innovations in techniques for analyzing cell-free DNA from spent embryo culture media are transforming traditional methods by eliminating the need for embryo cell extraction, thereby minimizing potential damage to embryos. This advancement not only enhances the safety and viability of the testing process but also aligns with growing consumer preferences for less invasive medical practices. As a result, the market is poised for significant growth with the adoption of these progressive methodologies.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Assessment
  • Regulatory Landscape

Global Preimplantation Genetic Testing Market Size by Test Type & CAGR (2025-2032)

  • Market Overview
  • Preimplantation Genetic Diagnosis (PGD)
  • Preimplantation Genetic Screening (PGS) / Aneuploidy Screening
  • HLA Typing / Embryo Matching
  • Others

Global Preimplantation Genetic Testing Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence In-Situ Hybridization (FISH)
  • Comparative Genomic Hybridization / Microarray
  • Single-Nucleotide Polymorphism (SNP) & AI-based Platforms

Global Preimplantation Genetic Testing Market Size by Category & CAGR (2025-2032)

  • Market Overview
  • Reagents & Consumables
  • Instruments / Platforms
  • Software & Bioinformatics Services

Global Preimplantation Genetic Testing Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Fertility Clinics / IVF Centres
  • Hospitals & Assisted Reproductive Technology (ART) Centres
  • Diagnostic Laboratories

Global Preimplantation Genetic Testing Market Size & CAGR (2025-2032)

  • North America (Test Type, Technology, Category, End-User)
    • US
    • Canada
  • Europe (Test Type, Technology, Category, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Test Type, Technology, Category, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Test Type, Technology, Category, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Test Type, Technology, Category, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Illumina Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CooperSurgical Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Natera Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genea Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holding AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Labcorp Holdings Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Invitae Corp.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Gene Technology IP
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Yikon Genomics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioarray S.L.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genesis Genetics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fulgent Genetics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Igenomix
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitrolife AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedGenome Labs
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CombiMatrix Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations